EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program

Elyse R Park iD, JoRean D Sicks iD, Brett M Goshe, Ilana F Gareen iD, Benjamin A Herman, Alexander Taurone, Seth Bittig, Angela Wangari Walter iD, Susan Regan, Rachel Rosen iD, Natalie Durieux, Autumn W Rasmussen und 18 weitere

Journal of Clinical Oncology · 20.08.2026 · 44 (24) · 2303-2315

DOI: 10.1200/jco-25-02267 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2026. Verfasst von Elyse R Park und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Neoplasms, Smoking Cessation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Persistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet tobacco treatment has not been integrated into community oncology settings. We conducted a trial of a virtual sustained tobacco treatment intervention across community oncology settings nationwide. METHODS This randomized controlled trial compared the effectiveness of sustained telehealth counseling plus medication (virtual sustained treatment [VST]) to referral to the National Cancer Institute (NCI) quitline (enhanced usual care [EUC]) in assisting patients recently diagnosed with cancer to quit smoking. The VST group received up to 11 synchronous telehealth sessions (four weekly, four biweekly, three monthly) of motivational counseling and up to 12 weeks of free nicotine replacement therapy (NRT). RESULTS From August 2019 to December 2022, 306 English- and Spanish-speaking patients were randomly assigned from 37 NCI Community Oncology Research Program community sites. Participants were 70.9% female; 86.3% was White; the median age was 57 years; and 45.4% had non–smoking-related tumors. A total of 221 of 302 (73.2%) smoked within 30 minutes of waking. Six-month, 7-day point abstinence rates were 28.4% (42 of 148) in the VST group versus 14.7% (21 of 143) in the EUC group; there were no significant treatment moderators. A total of 80.8% (126 of 156) of VST participants engaged in counseling, and 85.7% (108 of 126) were dispensed NRT. Participants who completed >8 sessions versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSmoking CessationAdultAgedFemaleHumansMaleMiddle AgedCounselingNational Cancer Institute (U.S.)Nicotine Replacement TherapyTelemedicineTobacco ControlUnited States

Autor:innen und Institutionen

  • Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
  • The Mongan Institute, Massachusetts General Hospital, Boston, MA.
  • Health Promotion and Resiliency Intervention Research Center, Massachusetts General Hospital, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Center for Biostatistics and Health Data Science, Brown University-ECOG-ACRIN Biostatistics Center, Providence, RI.
  • Department of Epidemiology, Brown University School of Public Health, Providence, RI.

ORCID-Profile: Elyse R Park, JoRean D Sicks, Ilana F Gareen, Angela Wangari Walter, Rachel Rosen, Douglas E Levy, Michael A Thompson, Michelle Lui, Irina Gonzalez, Lucy Finkelstein-Fox, Alyssa D Throckmorton, Ruth C Carlos, Lynne I Wagner, Jamie S Ostroff

Förderung

  • NCI NIH HHS

Zitieren

APA

Park, E. R., Sicks, J. D., Goshe, B. M., Gareen, I. F., Herman, B. A., Taurone, A., Bittig, S., Walter, A. W., Regan, S., Rosen, R., Durieux, N., Rasmussen, A. W., Levy, D. E., Nicolosi, G., Muzikansky, A., Thompson, M. A., Lui, M., Malloy, L., Gonzalez, I., …, & Ostroff, J. S. (2026). Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program. Journal of Clinical Oncology, 44(24), 2303-2315. https://doi.org/10.1200/jco-25-02267

Vancouver

Park ER, Sicks JD, Goshe BM, Gareen IF, Herman BA, Taurone A, et al. Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program. Journal of Clinical Oncology. 2026;44(24):2303-2315. doi:10.1200/jco-25-02267

BibTeX
@article{Park2026,
  author = {Park, Elyse R and Sicks, JoRean D and Goshe, Brett M and Gareen, Ilana F and Herman, Benjamin A and Taurone, Alexander and Bittig, Seth and Walter, Angela Wangari and Regan, Susan and Rosen, Rachel and Durieux, Natalie and Rasmussen, Autumn W and Levy, Douglas E and Nicolosi, Gabriella and Muzikansky, Alona and Thompson, Michael A and Lui, Michelle and Malloy, Laura and Gonzalez, Irina and Finkelstein-Fox, Lucy and Munson, Nathan D and Greenwade, Molly M and King, David M and Jenigiri, Bharat and Burnette, Brian L and Throckmorton, Alyssa D and Tingen, Martha S and Carlos, Ruth C and Wagner, Lynne I and Ostroff, Jamie S},
  title = {Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {24},
  pages = {2303--2315},
  doi = {10.1200/jco-25-02267}
}
Kostenlos starten →